(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

BRAIN TUMOR INVESTMENT FUND

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

BRAIN TUMOR INVESTMENT FUND

ST13

US500000097175797

Class

36

Filing

97175797

Registration

7050826

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

18

Latest update

05/09/2023

Trademark type

Word

Nice classes

36

Filing date

12/16/2021

Registration date

05/09/2023

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

05/09/2023

Last transaction

05/09/2023

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Supplemental Register

First use anywhere

05/01/2020

First use in commerce

05/01/2020

Drawing code

4

Owner type

99

Owner location

Newton, MA

Examiner

SNABB, SANDRA

Law office

N20

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

N. S. (pessoa física)

Representatives

Monica Riva Talley STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C.

Technical classification

Nice Classes

Class 36

Vienna Codes

No Vienna codes available.

Goods and services

Class 36

Investment of funds for charitable purposes

Publications

History of USPTO decisions and trademark events.

18 publications found

R.SR

REGISTERED-SUPPLEMENTAL REGISTER

05/09/2023

NRCS

NOTICE OF REGISTRATION CONFIRMATION EMAILED

05/09/2023

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

04/06/2023

ALIE

ASSIGNED TO LIE

03/30/2023

CNTA

APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER

03/14/2023

XAEC

EXAMINER'S AMENDMENT ENTERED

03/14/2023

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

03/14/2023

GNEA

EXAMINERS AMENDMENT E-MAILED

03/14/2023

CNEA

EXAMINERS AMENDMENT -WRITTEN

03/14/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/02/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/01/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

03/01/2023

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

09/21/2022

GNRT

NON-FINAL ACTION E-MAILED

09/21/2022

CNRT

NON-FINAL ACTION WRITTEN

09/21/2022

DOCK

ASSIGNED TO EXAMINER

09/15/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

12/21/2021

NWAP

NEW APPLICATION ENTERED

12/20/2021

Continuous trademark protection

Get notified about every new filing that threatens BRAIN TUMOR INVESTMENT FUND or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.